Read more (Abide Therapeutics website)
Abide Therapeutics announces collaborative agreement with the University of Oxford
7 November 2014
Oxford University and the Oxford University Hospitals NHS Trust have partnered with Abide Therapeutics to explore the therapeutic potential of serine hydrolases, a relatively underexplored class of drug targets. The collaboration will support new target discovery with the goal of running several early phase clinical studies to demonstrate proof of biology and therapeutic opportunity in man.